why choose us

First received: August 28, 2023

Clinical Trial: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects and Patients With Postbariatric Hypoglycemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: Phase 1/2 Randomized, Double-Blind, Placebo-controlled, Single Ascending Dose Study in Healthy Volunteers and Multiple Ascending Dose Study in Patients With Postbariatric Hypoglycemia to Evaluate

Brief Summary: The purpose of this trial is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of MBX 1416 in healthy volunteers and patients with postbariatric hypoglycemia.This study includes 2 parts.Part A involves a single dose of MBX 1416 or placebo taken as a subcutaneous injection (SC).Part B involves repeat doses of MBX 1416 or placebo taken as a subcutaneous injection (SC).

Read more